Abilify is intended for the treatment of schizophrenia. It is also indicated for the treatment of moderate to severe manic episodes in bipolar I Disorder and for the prevention of a new manic episode in patients who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.